4393-09-3 Usage
Description
2,3-Dimethoxybenzylamine is an organic compound that features a benzylamine core with two methoxy groups attached at the 2nd and 3rd positions on the benzene ring. This structure endows it with unique chemical properties and reactivity, making it a versatile building block in organic synthesis.
Uses
Used in Pharmaceutical and Organic Synthesis:
2,3-Dimethoxybenzylamine is used as a synthetic intermediate for the preparation of various organic compounds and pharmaceuticals. Its presence in the synthesis of di-, tri-, and tetrapeptide-linked dicatechol derivatives and 1-aryl-2,3-dihydro-1H-isoindoles (isoindolines) highlights its utility in creating complex molecular structures with potential applications in medicine and other fields.
In the synthesis of dicatechol derivatives, 2,3-Dimethoxybenzylamine serves as a key component that can be linked to peptides, potentially enhancing their stability and bioactivity. This makes it valuable in the development of new drugs and therapeutic agents.
Additionally, its role in the synthesis of 1-aryl-2,3-dihydro-1H-isoindoles (isoindolines) indicates its potential in creating novel chemical entities with diverse applications, such as in the design of new pharmaceuticals or materials with specific properties.
Check Digit Verification of cas no
The CAS Registry Mumber 4393-09-3 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,3,9 and 3 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 4393-09:
(6*4)+(5*3)+(4*9)+(3*3)+(2*0)+(1*9)=93
93 % 10 = 3
So 4393-09-3 is a valid CAS Registry Number.
InChI:InChI=1/C9H13NO2/c1-11-8-5-3-4-7(6-10)9(8)12-2/h3-5H,6,10H2,1-2H3
4393-09-3Relevant articles and documents
Arylalkylamine vanadium (V) salts for the treatment and/or prevention of Diabetes mellitus
-
Page/Page column 17, (2010/11/26)
This invention provides compounds of formula (IIA) and pharmaceutical compositions thereof, where M, a, b, and R1-R5 are as defined herein, for treating human type 1 and type 2 diabetes, particularly insulin-resistant diabetes. Pharmaceutical compositions comprising the compounds of formula (IIA) are also disclosed.
ARYLALKYLAMINE VANADIUM (V) SALTS FOR THE TREATMENT AND/OR PREVENTION OF DIABETES MELLITUS
-
Page/Page column 44, (2010/02/15)
This invention provides compounds and pharmaceutical compositions thereof for treating human type 1 and type 2 diabetes, particularly insulin-resistant diabetes.
INTRAMOLECULAR ADDITION OF AMINES TO CHIRAL VINYL SULFOXIDES, TOTAL SYNTHESIS OF (R)-(+)-CANADINE
Pyne, Stephen G.
, p. 4737 - 4740 (2007/10/02)
The intramolecular conjugate addition of an amine to the chiral vinyl sulfoxides 3 and 4 to give chiral isoquinolines 5 and 6 is reported.Isoquinoline 5 is converted to (R)-(+)-Canadine via an intramolecular Pummerer reaction.